Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

Go back to Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
Bruker Corporation (NASDAQ: BRKR) Delayed: 57.07 -4.93 (7.95%)
Previous Close $62.00    52 Week High $29.85 
Open $60.00    52 Week Low $19.59 
Day High $60.17    P/E 118.90 
Day Low $56.00    EPS $0.48 
Volume 1,921,334